UPClytics
View all cases

UPC CFI 625/2024

Oct 28, 2024·EP3831282: REMOTE MONITORING OF ANALYTE MEASUREMENTS

Case details
Status
Case Closed
Action
Generic
Category
Generic
Division
Paris LD
Technology
Healthcare Informatics
Language
English
Documents
Document titleDatePublic
Case Closure Formal Check2025-04-22Not public
Outcome of the Order2025-02-17Not public
Withdrawal final decision2025-02-17Public
Outcome of the Order2025-02-17Not public
Withdrawal final decision2025-02-17Public
Receipt2025-01-02Not public
Receipt2025-01-02Not public
2024 12 30 - UPC EP282 DNI - consent to Abbotts withdrawal PDFA2024-12-30Not public
2024 12 24 - UPC EP282 DNI - consent to Abbotts withdrawal2024-12-30Not public
Application for leave to withraw the action2024-12-30Not public
Preliminary-Objection2024-12-03Not public
Application pursuant to R. 361 RoP2024-12-02Not public
Panel-Appointment2024-11-29Not public
R9 ORDER2024-11-27Public
Notification Of Service2024-11-27Not public
Panel-Appointment2024-11-27Not public
Acknowledgement of access to case2024-11-27Not public
communicationCheck2024-11-15Not public
Document from EPO2024-11-15Not public
EPO-Request-for-case-pending2024-11-13Not public
Acknowledgement-of-lodging2024-11-13Not public
Formal-checks_Notification-of-positive-outcome2024-11-13Not public
Annex A8 - Rejoinder to the Reply to the Statement of Defence dated of 16 September 20242024-10-28Not public
Proof of payment DNI2024-10-28Not public
12968-01201-241028 -Letter to Central Division signed2024-10-28Not public
Annex A4 - EP-3 831 282 B1.pdf2024-10-28Not public
Annex A3 - Court order regarding the R263 Application2024-10-28Not public
Annex A5 - Extract from the register of the EPO regarding EP-3 831 282 B12024-10-28Not public
Annex A1 - Abbott R263 Application2024-10-28Not public
Annex A6 - Statement of Defence dated of 15 March 20242024-10-28Not public
12968-01201-241028 - DNI Statement LLU App 4 12 0 signed2024-10-28Not public
Annex A7 - Rejoinder to the Reply to the Statement of Defence dated of 15 July 20242024-10-28Not public
Annex A2 - Dexcom comments following the R263 Application2024-10-28Not public